N4 Pharma plc (LON:N4P) is the topic of conversation when SP Angel’s Analyst Vadim Alexandre caught up with DirectorsTalk for an exclusive interview. Q1: You’ve issued a new research note..
N4 Pharma plc (LON:N4P) is the topic of conversation when SP Angel Analyst Vadim Alexandre joins DirectorsTalk. Vadim talks us through the main points of their latest research note, explains..
The share price for Morses Club company symbol: LON:MCL has gained 4.22% or 3.5 points throughout today’s trading session so far. Investors seem confident while the stock has been in..
N4 Pharma plc (LON:N4P) Chief Executive Officer Nigel Theobald caught up with DirectorsTalk to discuss the Material Transfer Agreements, collaborating with more partners, the in vivo studies, how the work..
N4 Pharma plc (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss its operations update. Nigel explains what is involved in the Material Transfer Agreements that have been announced, whether these..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has provided an update on collaboration discussions and its ongoing in vivo work programme...
N4 Pharma plc (LON:N4P) Chief Executive Officer Nigel Theobald caught up with DirectorsTalk to discuss final results, updates on the three work streams, the European patent for Nuvec & what..
N4 Pharma Plc (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss results for the year ended 31 December 2020. Nigel talks us through the highlights of the year, updates us..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced its audited results for the year ended 31 December..
The share price for Kingfisher ticker code: LON:KGF has moved up 2.58% or 7.2 points throughout today’s trading session so far. Investors have remained positive throughout the session. Range high..
The share price for Morses Club with ticker code: LON:MCL has stepped up 4.44% or 1.93 points during today’s session so far. Traders have so far held a positive outlook..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced that it has raised £2 million (before expenses) through..
Shares of Morses Club ticker code: LON:MCL has moved up 9.41% or 4 points during today’s session so far. Market buyers are a positive bunch throughout the trading session. The..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has provided the following update on its ongoing research collaboration agreement with..
The share price for Jubilee Metals Group EPIC code: LON:JLP has moved up 4.35% or 0.37 points during today’s session so far. Investors seem confident during this period. Range high..
The trading price for N4 Pharma company symbol: LON:N4P has climbed 6.54% or 0.43 points throughout the session so far. Traders have stayed positive throughout the trading session. The high..
N4 Pharma plc (LON:N4P) is the topic of conversation when SP Angel Analyst and Head of Healthcare Vadim Alexandre joins DirectorsTalk. Vadim having just initiated on the company explains what..
N4 Pharma plc (LON:N4P) Chief Executive Officer Nigel Theobald caught up with DirectorsTalk for an exclusive interview to discuss their latest operational update, the importance of demonstrating formulation, key milestones..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced that it has appointed Nanomerics Limited to investigate the..
N4 Pharma plc (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss its latest operational update. Nigel talks us through the key highlights, explains why demonstrating formulation stability is so important,..
